authors
- Neumiller, Joshua J
- McCoy, Rozalina G
- Herrin, Jeph
- Swarna, Kavya Sindhu
- Polley, Eric C
- Galindo, Rodolfo J
- Umpierrez, Guillermo E
- Deng, Yihong
- Joseph S. Ross, MD, MHS
- Mickelson, Mindy M
Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- October 8, 2024
published in
has subject area
- Aged
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Dipeptidyl-Peptidase IV Inhibitors
- Female
- Glucagon-Like Peptide-1 Receptor Agonists
- Heart Disease Risk Factors
- Humans
- Hypoglycemic Agents
- Male
- Middle Aged
- Renal Insufficiency, Chronic
- Retrospective Studies
- Sodium-Glucose Transporter 2 Inhibitors
- Sulfonylurea Compounds
- Treatment Outcome